Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations.

Höglander EK, Nord S, Wedge DC, Lingjærde OC, Silwal-Pandit L, Gythfeldt HV, Vollan HKM, Fleischer T, Krohn M, Schlitchting E, Borgen E, Garred Ø, Holmen MM, Wist E, Naume B, Van Loo P, Børresen-Dale AL, Engebraaten O, Kristensen V.

Genome Med. 2018 Nov 29;10(1):92. doi: 10.1186/s13073-018-0601-y.

2.

Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment.

Madssen TS, Thune I, Flote VG, Lundgren S, Bertheussen GF, Frydenberg H, Wist E, Schlichting E, Schäfer H, Fjøsne HE, Vettukattil R, Lømo J, Bathen TF, Giskeødegård GF.

Br J Cancer. 2018 Oct;119(9):1144-1154. doi: 10.1038/s41416-018-0211-x. Epub 2018 Nov 7.

PMID:
30401977
3.

Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes.

Lofterød T, Mortensen ES, Nalwoga H, Wilsgaard T, Frydenberg H, Risberg T, Eggen AE, McTiernan A, Aziz S, Wist EA, Stensvold A, Reitan JB, Akslen LA, Thune I.

BMC Cancer. 2018 Jun 15;18(1):654. doi: 10.1186/s12885-018-4568-2.

4.

Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.

Ohnstad HO, Borgen E, Falk RS, Lien TG, Aaserud M, Sveli MAT, Kyte JA, Kristensen VN, Geitvik GA, Schlichting E, Wist EA, Sørlie T, Russnes HG, Naume B.

Breast Cancer Res. 2017 Nov 14;19(1):120. doi: 10.1186/s13058-017-0911-9.

5.

Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial.

Sonke GS, Hart LL, Campone M, Erdkamp F, Janni W, Verma S, Villanueva C, Jakobsen E, Alba E, Wist E, Favret AM, Bachelot T, Hegg R, Wheatley-Price P, Souami F, Sutradhar S, Miller M, Germa C, Burris HA.

Breast Cancer Res Treat. 2018 Feb;167(3):659-669. doi: 10.1007/s10549-017-4523-y. Epub 2017 Oct 22.

6.

Erratum: Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer.

Vaysse C, Lømo J, Garred Ø, Fjeldheim F, Lofteroed T, Schlichting E, McTiernan A, Frydenberg H, Husøy A, Lundgren S, Fagerland MW, Richardsen E, Wist EA, Muller C, Thune I.

NPJ Breast Cancer. 2017 Sep 5;3:35. doi: 10.1038/s41523-017-0030-x. eCollection 2017.

7.

Prostate and breast cancer in four Nordic countries: A comparison of incidence and mortality trends across countries and age groups 1975-2013.

Kvåle R, Myklebust TÅ, Engholm G, Heinävaara S, Wist E, Møller B.

Int J Cancer. 2017 Dec 1;141(11):2228-2242. doi: 10.1002/ijc.30924. Epub 2017 Aug 26.

8.

Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer.

Vaysse C, Lømo J, Garred Ø, Fjeldheim F, Lofteroed T, Schlichting E, McTiernan A, Frydenberg H, Husøy A, Lundgren S, Fagerland MW, Richardsen E, Wist EA, Muller C, Thune I.

NPJ Breast Cancer. 2017 May 3;3:19. doi: 10.1038/s41523-017-0015-9. eCollection 2017. Erratum in: NPJ Breast Cancer. 2017 Sep 5;3:35.

9.

The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer.

Silwal-Pandit L, Nord S, von der Lippe Gythfeldt H, Møller EK, Fleischer T, Rødland E, Krohn M, Borgen E, Garred Ø, Olsen T, Vu P, Skjerven H, Fangberget A, Holmen MM, Schlitchting E, Wille E, Nordberg Stokke M, Moen Vollan HK, Kristensen V, Langerød A, Lundgren S, Wist E, Naume B, Lingjærde OC, Børresen-Dale AL, Engebraaten O.

Clin Cancer Res. 2017 Aug 15;23(16):4662-4670. doi: 10.1158/1078-0432.CCR-17-0160. Epub 2017 May 9.

10.

Fatigue During and After Breast Cancer Therapy-A Prospective Study.

Reinertsen KV, Engebraaten O, Loge JH, Cvancarova M, Naume B, Wist E, Edvardsen H, Wille E, Bjøro T, Kiserud CE.

J Pain Symptom Manage. 2017 Mar;53(3):551-560. doi: 10.1016/j.jpainsymman.2016.09.011. Epub 2016 Dec 29.

PMID:
28042070
11.

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, Sonke GS, Paluch-Shimon S, Campone M, Blackwell KL, André F, Winer EP, Janni W, Verma S, Conte P, Arteaga CL, Cameron DA, Petrakova K, Hart LL, Villanueva C, Chan A, Jakobsen E, Nusch A, Burdaeva O, Grischke EM, Alba E, Wist E, Marschner N, Favret AM, Yardley D, Bachelot T, Tseng LM, Blau S, Xuan F, Souami F, Miller M, Germa C, Hirawat S, O'Shaughnessy J.

N Engl J Med. 2016 Nov 3;375(18):1738-1748. Epub 2016 Oct 7. Erratum in: N Engl J Med. 2018 Dec 27;379(26):2582.

12.

Polymorphisms in the estrogen receptor alpha gene (ESR1), daily cycling estrogen and mammographic density phenotypes.

Fjeldheim FN, Frydenberg H, Flote VG, McTiernan A, Furberg AS, Ellison PT, Barrett ES, Wilsgaard T, Jasienska G, Ursin G, Wist EA, Thune I.

BMC Cancer. 2016 Oct 7;16(1):776.

13.

Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer.

Flote VG, Vettukattil R, Bathen TF, Egeland T, McTiernan A, Frydenberg H, Husøy A, Finstad SE, Lømo J, Garred Ø, Schlichting E, Wist EA, Thune I.

Lipids Health Dis. 2016 Mar 12;15:56. doi: 10.1186/s12944-016-0225-4.

14.

Aspects of posttraumatic stress disorder in long-term testicular cancer survivors: cross-sectional and longitudinal findings.

Dahl AA, Østby-Deglum M, Oldenburg J, Bremnes R, Dahl O, Klepp O, Wist E, Fosså SD.

J Cancer Surviv. 2016 Oct;10(5):842-9. doi: 10.1007/s11764-016-0529-4. Epub 2016 Feb 26.

PMID:
26920871
15.

Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival.

Frydenberg H, Thune I, Lofterød T, Mortensen ES, Eggen AE, Risberg T, Wist EA, Flote VG, Furberg AS, Wilsgaard T, Akslen LA, McTiernan A.

Breast Cancer Res Treat. 2016 Jan;155(2):345-54. doi: 10.1007/s10549-015-3671-1. Epub 2016 Jan 6.

PMID:
26740213
16.

High-density lipoprotein-cholesterol, daily estradiol and progesterone, and mammographic density phenotypes in premenopausal women.

Flote VG, Frydenberg H, Ursin G, Iversen A, Fagerland MW, Ellison PT, Wist EA, Egeland T, Wilsgaard T, McTiernan A, Furberg AS, Thune I.

Cancer Prev Res (Phila). 2015 Jun;8(6):535-44. doi: 10.1158/1940-6207.CAPR-14-0267. Epub 2015 Mar 24.

17.

Gene variations in oestrogen pathways, CYP19A1, daily 17β-estradiol and mammographic density phenotypes in premenopausal women.

Flote VG, Furberg AS, McTiernan A, Frydenberg H, Ursin G, Iversen A, Lofteroed T, Ellison PT, Wist EA, Egeland T, Wilsgaard T, Makar KW, Chang-Claude J, Thune I.

Breast Cancer Res. 2014 Dec 19;16(6):499. doi: 10.1186/s13058-014-0499-2.

18.

Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.

Naume B, Synnestvedt M, Falk RS, Wiedswang G, Weyde K, Risberg T, Kersten C, Mjaaland I, Vindi L, Sommer HH, Sætersdal AB, Rypdal MC, Bendigtsen Schirmer C, Wist EA, Borgen E.

J Clin Oncol. 2014 Dec 1;32(34):3848-57. doi: 10.1200/JCO.2014.56.9327. Epub 2014 Nov 3.

PMID:
25366688
19.

A randomized clinical trial of the efficacy of a self-care intervention to improve cancer pain management.

Rustøen T, Valeberg BT, Kolstad E, Wist E, Paul S, Miaskowski C.

Cancer Nurs. 2014 Jan-Feb;37(1):34-43. doi: 10.1097/NCC.0b013e3182948418.

PMID:
23666269
20.

Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study.

Synnestvedt M, Borgen E, Wist E, Wiedswang G, Weyde K, Risberg T, Kersten C, Mjaaland I, Vindi L, Schirmer C, Nesland JM, Naume B.

BMC Cancer. 2012 Dec 22;12:616. doi: 10.1186/1471-2407-12-616.

21.

Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer.

Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist EA, Bjøro T, Wentzel-Larsen T, Dahl O; Norwegian Urology Cancer Group (NUCG) III study group.

Br J Cancer. 2012 Nov 20;107(11):1833-9. doi: 10.1038/bjc.2012.471.

22.

The PRO-SELF(©) Pain Control Program improves patients' knowledge of cancer pain management.

Rustøen T, Valeberg BT, Kolstad E, Wist E, Paul S, Miaskowski C.

J Pain Symptom Manage. 2012 Sep;44(3):321-30. doi: 10.1016/j.jpainsymman.2011.09.015. Epub 2012 Jun 15.

PMID:
22704056
23.

Weekly Paclitaxel plus Capecitabine versus Docetaxel Every 3 Weeks plus Capecitabine in Metastatic Breast Cancer.

Wist EA, Mjaaland I, Løkkevik E, Sommer HH.

J Oncol. 2012;2012:862921. doi: 10.1155/2012/862921. Epub 2012 Jan 15.

24.

Cardiotoxic effects of trastuzumab.

Hysing J, Wist E.

Tidsskr Nor Laegeforen. 2011 Nov 15;131(22):2239-41. doi: 10.4045/tidsskr.10.0862. Review. English, Norwegian.

25.

Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathway.

Reinertsen KV, Grenaker Alnæs GI, Landmark-Høyvik H, Loge JH, Wist E, Kristensen VN, Fosså SD, Edvardsen H.

Brain Behav Immun. 2011 Oct;25(7):1376-83. doi: 10.1016/j.bbi.2011.04.001. Epub 2011 Apr 7.

PMID:
21496483
26.

Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA study.

Andersson M, Lidbrink E, Bjerre K, Wist E, Enevoldsen K, Jensen AB, Karlsson P, Tange UB, Sørensen PG, Møller S, Bergh J, Langkjer ST.

J Clin Oncol. 2011 Jan 20;29(3):264-71. doi: 10.1200/JCO.2010.30.8213. Epub 2010 Dec 13.

PMID:
21149659
27.

Predictors and course of chronic fatigue in long-term breast cancer survivors.

Reinertsen KV, Cvancarova M, Loge JH, Edvardsen H, Wist E, Fosså SD.

J Cancer Surviv. 2010 Dec;4(4):405-14. doi: 10.1007/s11764-010-0145-7. Epub 2010 Sep 23.

28.

A controlled study of risk factors for disease and current problems in long-term testicular cancer survivors.

Dahl CF, Haugnes HS, Bremnes R, Dahl O, Fosså SD, Klepp O, Wist E, Dahl AA.

J Cancer Surviv. 2010 Sep;4(3):256-65. doi: 10.1007/s11764-010-0133-y. Epub 2010 Jun 24.

PMID:
20574815
29.

Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy.

Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, Dahl O; Norwegian Urology Cancer Group III study group.

Eur Urol. 2010 Jul;58(1):134-40. doi: 10.1016/j.eururo.2010.03.041. Epub 2010 Apr 2.

PMID:
20395037
30.

A study of coping in long-term testicular cancer survivors.

Rutskij R, Gaarden T, Bremnes R, Dahl O, Finset A, Fossa SD, Klepp O, Sorebo O, Wist E, Dahl AA.

Psychol Health Med. 2010 Mar;15(2):146-58. doi: 10.1080/13548501003623955.

PMID:
20391232
31.

[Survival after breast cancer--differences between Norwegian counties].

Kalager M, Kåresen R, Wist E.

Tidsskr Nor Laegeforen. 2009 Dec 17;129(24):2595-600. doi: 10.4045/tidsskr.09.0024. Norwegian.

32.

Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.

Brydøy M, Oldenburg J, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, Hauge ER, Dahl O, Fosså SD.

J Natl Cancer Inst. 2009 Dec 16;101(24):1682-95. doi: 10.1093/jnci/djp413.

33.

Adult height, insulin, and 17beta-estradiol in young women.

Finstad SE, Emaus A, Tretli S, Jasienska G, Ellison PT, Furberg AS, Wist EA, Thune I.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1477-83. doi: 10.1158/1055-9965.EPI-08-0972.

34.

The personality trait of neuroticism is strongly associated with long-term morbidity in testicular cancer survivors.

Grov EK, Fosså SD, Bremnes RM, Dahl O, Klepp O, Wist E, Dahl AA.

Acta Oncol. 2009;48(6):842-9. doi: 10.1080/02841860902795232.

PMID:
19412812
35.

Thyroid function in women after multimodal treatment for breast cancer stage II/III: comparison with controls from a population sample.

Reinertsen KV, Cvancarova M, Wist E, Bjøro T, Dahl AA, Danielsen T, Fosså SD.

Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):764-70. doi: 10.1016/j.ijrobp.2008.11.037. Epub 2009 Mar 13.

PMID:
19286332
36.

Fear of recurrence in long-term testicular cancer survivors.

Skaali T, Fosså SD, Bremnes R, Dahl O, Haaland CF, Hauge ER, Klepp O, Oldenburg J, Wist E, Dahl AA.

Psychooncology. 2009 Jun;18(6):580-8. doi: 10.1002/pon.1437.

PMID:
18855944
37.

Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors.

Haugnes HS, Aass N, Fosså SD, Dahl O, Klepp O, Wist EA, Wilsgaard T, Bremnes RM.

J Cancer Surviv. 2008 Sep;2(3):128-37. doi: 10.1007/s11764-008-0054-1. Epub 2008 May 29.

PMID:
18792787
38.

TENS and optokinetic stimulation in neglect therapy after cerebrovascular accident: a randomized controlled study.

Schröder A, Wist ER, Hömberg V.

Eur J Neurol. 2008 Sep;15(9):922-7. doi: 10.1111/j.1468-1331.2008.02229.x. Epub 2008 Jul 15.

PMID:
18637956
39.

Chronic cancer-related fatigue in long-term survivors of testicular cancer.

Orre IJ, Fosså SD, Murison R, Bremnes R, Dahl O, Klepp O, Loge JH, Wist E, Dahl AA.

J Psychosom Res. 2008 Apr;64(4):363-71. doi: 10.1016/j.jpsychores.2008.01.002.

PMID:
18374735
40.

Trastuzumab in adjuvant breast cancer therapy. A model based cost-effectiveness analysis.

Norum J, Olsen JA, Wist EA, Lønning PE.

Acta Oncol. 2007;46(2):153-64.

PMID:
17453363
41.

Is the sexual function compromised in long-term testicular cancer survivors?

Dahl AA, Bremnes R, Dahl O, Klepp O, Wist E, Fosså SD.

Eur Urol. 2007 Nov;52(5):1438-47. Epub 2007 Mar 1.

PMID:
17350159
42.

Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy.

Wilking N, Lidbrink E, Wiklund T, Erikstein B, Lindman H, Malmström P, Kellokumpu-Lehtinen P, Bengtsson NO, Söderlund G, Anker G, Wist E, Ottosson S, Salminen E, Ljungman P, Holte H, Nilsson J, Blomqvist C, Bergh J.

Ann Oncol. 2007 Apr;18(4):694-700. Epub 2007 Feb 13.

PMID:
17301072
43.

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

Smith I, Procter M, Gelber RD, Guillaume S, Feyereislova A, Dowsett M, Goldhirsch A, Untch M, Mariani G, Baselga J, Kaufmann M, Cameron D, Bell R, Bergh J, Coleman R, Wardley A, Harbeck N, Lopez RI, Mallmann P, Gelmon K, Wilcken N, Wist E, Sánchez Rovira P, Piccart-Gebhart MJ; HERA study team.

Lancet. 2007 Jan 6;369(9555):29-36.

PMID:
17208639
44.

Components of the metabolic syndrome in long-term survivors of testicular cancer.

Haugnes HS, Aass N, Fosså SD, Dahl O, Klepp O, Wist EA, Svartberg J, Wilsgaard T, Bremnes RM.

Ann Oncol. 2007 Feb;18(2):241-8. Epub 2006 Oct 23.

PMID:
17060482
45.

Monitoring of disseminated tumor cells in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy.

Drageset V, Nesland JM, Erikstein B, Skovlund E, Sommer H, Anker G, Wist E, Lundgren S, Bergh J, Kvalheim G.

Int J Cancer. 2006 Jun 1;118(11):2877-81.

46.

Paternity following treatment for testicular cancer.

Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, Dahl O.

J Natl Cancer Inst. 2005 Nov 2;97(21):1580-8.

PMID:
16264178
47.

Blood pressure and body mass index in long-term survivors of testicular cancer.

Sagstuen H, Aass N, Fosså SD, Dahl O, Klepp O, Wist EA, Wilsgaard T, Bremnes RM.

J Clin Oncol. 2005 Aug 1;23(22):4980-90.

PMID:
16051950
48.

Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer.

Mykletun A, Dahl AA, Haaland CF, Bremnes R, Dahl O, Klepp O, Wist E, Fosså SD.

J Clin Oncol. 2005 May 1;23(13):3061-8.

PMID:
15860864
49.

Study of anxiety disorder and depression in long-term survivors of testicular cancer.

Dahl AA, Haaland CF, Mykletun A, Bremnes R, Dahl O, Klepp O, Wist E, Fosså SD.

J Clin Oncol. 2005 Apr 1;23(10):2389-95.

PMID:
15800331
50.

The association between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men in a general population sample.

Thorsen L, Nystad W, Stigum H, Dahl O, Klepp O, Bremnes RM, Wist E, Fosså SD.

Support Care Cancer. 2005 Aug;13(8):637-46. Epub 2005 Mar 9.

PMID:
15756585

Supplemental Content

Support Center